Analystreport

Biohaven Pharmaceutical Holding Co Ltd (NASDAQ: BHVN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Biohaven Ltd. Common Shares  (BHVN) 
Last biohaven ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com